MARKET

ORMP

ORMP

Oramed Pharmaceuticals Inc
NASDAQ
2.070
+0.010
+0.49%
After Hours: 2.070 0 0.00% 18:27 02/03 EST
OPEN
2.020
PREV CLOSE
2.060
HIGH
2.110
LOW
2.005
VOLUME
1.22M
TURNOVER
0
52 WEEK HIGH
13.73
52 WEEK LOW
1.810
MARKET CAP
80.97M
P/E (TTM)
-1.9981
1D
5D
1M
3M
1Y
5Y
Healthcare Outlook 2023
Seeking Alpha · 01/23 15:02
Oramed stock falls 10% as Wainwright cuts rating on potential halt of drug trial
Seeking Alpha · 01/17 16:40
HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral
Benzinga · 01/17 11:12
--HC Wainwright Downgrades Oramed Pharmaceuticals to Neutral From Buy
--HC Wainwright Downgrades Oramed Pharmaceuticals to Neutral From Buy
MT Newswires · 01/17 07:27
Evaluating Oramed After Their P3 Type 2 Diabetes Trial Failure
Seeking Alpha · 01/15 07:49
Hot Stocks: CTSH rises on guidance; LOGI slumps; CAT hits 52-week high; ORMP plunges 76%
Seeking Alpha · 01/13 00:00
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%
Benzinga · 01/12 19:28
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/12 18:19
More
About ORMP
Oramed Pharmaceuticals Inc. is a pharmaceutical company. It is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Its pipeline products are ORMD-0801 Type 1, ORM-0801 Type 2 and ORMD-0901. Its flagship product, ORMD-0801, is an orally ingestible insulin capsule. It is anticipated for use as a complementary agent to insulin injections in the treatment of Type I diabetes Mellitus (T1DM) and T2Dm disease. This treatment regimen should allow for fewer daily injections and a lower frequency of blood glucose fluctuations in cases of unstable and brittle T1DM. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which is a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas. The Company's other product is ORMD-0901, an orally ingestible GLP-1 capsule.

Webull offers kinds of Oramed Pharmaceuticals, Inc. stock information, including NASDAQ:ORMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORMP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ORMP stock methods without spending real money on the virtual paper trading platform.